Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Formula: C25H27F4N3O3S
orally) improves survival compare to placebo
which is a potent and selective ATP-competitive CDK inhibitor
is a GluN2C/GluN2D subunit-selective NMDA receptor potentiator
XL184 (Cabozantinib) cuolin-1 Formula: C25H27F4N3O3SCabozantinib, also known as XL 184 or BMS 907351, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several tyrosine receptor kinases. Specifically, cabozantinib appears to have a strong affinity for the hepatocyte growth factor receptor (Met) and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in inhibition of